NOS2 and Alzheimer disease: In neurodegenerative diseases, such as AD, RAGE upregulation has been implicated in the stimulation of neuronal APP expression (e.g., [55]), and APP has been demonstrated to induce microglial activation accompanied by an increased inducible NO synthase expression [56].